Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

[1]  M. Tsuneyoshi,et al.  N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[3]  R. Davis,et al.  Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. , 1998, Cancer research.

[4]  R. Godbout,et al.  Overexpression of a DEAD Box Protein (DDX1) in Neuroblastoma and Retinoblastoma Cell Lines* , 1998, The Journal of Biological Chemistry.

[5]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.

[6]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[7]  P. Brown,et al.  Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.

[8]  O. Kallioniemi,et al.  Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.

[9]  Thomas Ried,et al.  Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping , 1997, Nature Genetics.

[10]  K. Pritchard-Jones,et al.  Novel formation and amplification of the PAX7‐FKHR fusion gene in a case of alveolar rhabdomyosarcoma , 1996 .

[11]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[12]  K. Pritchard-Jones,et al.  Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. , 1996, Cancer research.

[13]  C. Higgins,et al.  A DEAD-box RNA helicase in the Escherichia coli RNA degradosome , 1996, Nature.

[14]  P. Lollini,et al.  Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. , 1996, Oncogene.

[15]  J. Lunec,et al.  Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. , 1996, Oncogene.

[16]  J. Squire,et al.  Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. , 1996, The American journal of pathology.

[17]  D. Ward,et al.  Karyotyping human chromosomes by combinatorial multi-fluor FISH , 1996, Nature Genetics.

[18]  M. Silen.  Classification of rhabdomyosarcomas and related sarcomas: W.A. Newton, Jr, E.A. Gehan, B.L. Webber, et al. Cancer 76:1073–1085, (September), 1995 , 1996 .

[19]  M. Schwab,et al.  The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma , 1996, Genes, chromosomes & cancer.

[20]  T. Matsunaga,et al.  Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus , 1996, Genes, chromosomes & cancer.

[21]  J. Squire,et al.  Application of a simplified comparative genomic hybridization technique to screen for gene amplification in pediatric solid tumors. , 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

[22]  C. Manohar,et al.  Co‐amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma , 1995, Genes, chromosomes & cancer.

[23]  Joseph,et al.  Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. , 1995, Blood.

[24]  S. Weitzman,et al.  Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. , 1995, Oncogene.

[25]  J. Biegel,et al.  Detection of the t(2;13)(q35;q14) and PAX3‐FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization , 1995, Genes, chromosomes & cancer.

[26]  N. Dracopoli,et al.  Current protocols in human genetics , 1994 .

[27]  D. Storm,et al.  Regulation of p68 RNA helicase by calmodulin and protein kinase C. , 1994, The Journal of biological chemistry.

[28]  Isabelle lost,et al.  mRNAs can be stabilized by DEAD-box proteins , 1994, Nature.

[29]  J. Biegel,et al.  Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.

[30]  Mark L. Greenberg,et al.  MYCN gene amplification in rhabdomyosarcoma , 1994, Cancer.

[31]  P. Waber,et al.  Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. , 1993, Cancer research.

[32]  A. Look,et al.  Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. , 1993, Cancer research.

[33]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[34]  J. Squire,et al.  Amplification of a DEAD box protein gene in retinoblastoma cell lines. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Leland Hartwell,et al.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.

[36]  T. Triche,et al.  Cytogenetic studies in subgroups of rhabdomyosarcoma , 1992, Genes, chromosomes & cancer.

[37]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .

[38]  L. Diller.  Rhabdomyosarcoma and other soft tissue sarcomas of childhood , 1992, Current opinion in oncology.

[39]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[40]  P Linder,et al.  D‐E‐A‐D protein family of putative RNA helicases , 1992, Molecular microbiology.

[41]  H. B. Marsden,et al.  N‐myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS , 1990, International journal of cancer.

[42]  N. Sonenberg,et al.  Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F , 1990, Molecular and cellular biology.

[43]  C. Sapienza,et al.  A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting , 1989 .

[44]  A. Look,et al.  Amplification of the gli gene in childhood sarcomas. , 1989, Cancer research.

[45]  W. Cavenee,et al.  Molecular differential pathology of rhabdomyosarcoma , 1989, Genes, chromosomes & cancer.

[46]  S. Dodd,et al.  Rhabdomyosarcoma in children: A histological and immunohistochemical study of 59 cases , 1989, The Journal of pathology.

[47]  B. Lampkin,et al.  Chromosomal analysis of sixteen human rhabdomyosarcomas. , 1988, Cancer research.

[48]  P. Meltzer,et al.  Nonrandom chromosome alterations in rhabdomyosarcoma. , 1985, Cancer genetics and cytogenetics.

[49]  P. Houghton,et al.  Development of resistance to vincristine in a childhood rhabdomyosarcoma growing in immune‐deprived mice , 1981, International journal of cancer.

[50]  W. W. Nichols,et al.  Definition of a continuous human cell line derived from neuroblastoma. , 1970, Cancer research.

[51]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[52]  J. Biegel,et al.  In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. , 1996, Human molecular genetics.

[53]  A. Bernheim,et al.  MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14). , 1996, Cytogenetics and cell genetics.

[54]  A. Sandberg,et al.  Cytogenetics of Bone and Soft Tissue Tumors , 1995 .